Published in Nat Med on January 01, 2006
Central nervous system control of metabolism. Nature (2012) 1.83
SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab (2008) 4.89
Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab (2007) 4.74
Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med (2002) 4.69
Hypothalamic K(ATP) channels control hepatic glucose production. Nature (2005) 4.56
Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem (2005) 4.32
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med (2008) 4.25
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci (2002) 3.64
Regulation of fasted blood glucose by resistin. Science (2004) 3.54
Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med (2006) 3.24
Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med (2003) 3.21
Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest (2003) 3.11
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology (2003) 3.04
Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest (2003) 2.95
Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat Med (2008) 2.91
Central administration of oleic acid inhibits glucose production and food intake. Diabetes (2002) 2.91
Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes (2002) 2.90
A brain-liver circuit regulates glucose homeostasis. Cell Metab (2005) 2.83
Hypothalamic sensing of fatty acids. Nat Neurosci (2005) 2.67
Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat Med (2005) 2.66
Regulation of blood glucose by hypothalamic pyruvate metabolism. Science (2005) 2.28
Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest (2006) 2.13
Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest (2006) 1.94
Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci (2006) 1.87
Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest (2004) 1.83
Disulfide-dependent multimeric assembly of resistin family hormones. Science (2004) 1.76
Critical role of STAT3 in leptin's metabolic actions. Cell Metab (2006) 1.70
The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis. Mol Cell Biol (2009) 1.69
Central leptin acutely reverses diet-induced hepatic insulin resistance. Diabetes (2005) 1.69
Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest (2005) 1.55
Activation of hypothalamic S6 kinase mediates diet-induced hepatic insulin resistance in rats. J Clin Invest (2008) 1.53
Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med (2007) 1.51
Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology (2003) 1.47
Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes (2009) 1.46
Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem (2004) 1.44
Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes (2007) 1.42
Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes (2004) 1.39
Severe impairment in liver insulin signaling fails to alter hepatic insulin action in conscious mice. J Clin Invest (2005) 1.35
Melanocortin-independent effects of leptin on hepatic glucose fluxes. J Biol Chem (2004) 1.35
Identification of a biochemical link between energy intake and energy expenditure. J Clin Invest (2002) 1.29
Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes (2002) 1.13
Identification and characterization of a novel phosphorylation site on the GluR1 subunit of AMPA receptors. Mol Cell Neurosci (2007) 1.12
Leptin resistance during aging is independent of fat mass. Diabetes (2002) 1.12
Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest (2007) 1.10
Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2. FASEB J (2008) 1.08
Hypothalamic protein kinase C regulates glucose production. Diabetes (2008) 1.07
Role of transcription factor NFAT in glucose and insulin homeostasis. Mol Cell Biol (2006) 1.02
Hypothalamic leucine metabolism regulates liver glucose production. Diabetes (2012) 0.99
Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects. Diabetes (2002) 0.98
Mediobasal hypothalamic SIRT1 is essential for resveratrol's effects on insulin action in rats. Diabetes (2011) 0.98
Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. J Med Chem (2011) 0.97
Intracerebroventricular leptin regulates hepatic cholesterol metabolism. Biochem J (2004) 0.96
Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormones involved in food intake and metabolism: insulin and melanocortins. Neuropharmacology (2007) 0.92
Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway. Atherosclerosis (2002) 0.91
The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin. Obesity (Silver Spring) (2012) 0.90
Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents. Biopolymers (2012) 0.89
Differential effects of oxyntomodulin and GLP-1 on glucose metabolism. Am J Physiol Endocrinol Metab (2012) 0.87
Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes (2002) 0.86
Effects of peripherally administered neuromedin U on energy and glucose homeostasis. Endocrinology (2011) 0.86
Hypothalamic sensing of circulating lactate regulates glucose production. J Cell Mol Med (2010) 0.84
DPP-IV-resistant, long-acting oxyntomodulin derivatives. J Pept Sci (2011) 0.84
PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes. Bioorg Med Chem (2012) 0.83
Effects of fasting and glucocorticoids on hepatic gluconeogenesis assessed using two independent methods in vivo. Am J Physiol Endocrinol Metab (2002) 0.83
Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide. J Pept Sci (2013) 0.81
Free fatty acids as mediators of adaptive compensatory responses to insulin resistance in dexamethasone-treated rats. Diabetes Metab Res Rev (2008) 0.81
Einstein's Institute for Aging Research: collaborative and programmatic approaches in the search for successful aging. Exp Gerontol (2004) 0.81
A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity. Bioorg Med Chem (2013) 0.80
Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes. Endocrine (2002) 0.78
Quantification of intact and truncated stromal cell-derived factor-1α in circulation by immunoaffinity enrichment and tandem mass spectrometry. J Am Soc Mass Spectrom (2014) 0.78
Effects of life-long exercise on circulating free fatty acids and muscle triglyceride content in ageing rats. Exp Gerontol (2004) 0.77
A new piece in the diabetes puzzle. Nat Med (2002) 0.77
An audience with Luciano Rossetti. Interview by Bethan Hughes. Nat Rev Drug Discov (2010) 0.75
Erratum. Mediobasal Hypothalamic SIRT1 Is Essential for Resveratrol's Effects on Insulin Action in Rats. Diabetes 2011;60:2691-2700. Diabetes (2017) 0.75
Erratum. Mediobasal Hypothalamic SIRT1 Is Essential for Resveratrol's Effects on Insulin Action in Rats. Diabetes 2011;60:2691-2700. Diabetes (2017) 0.75